China's customs to no longer supervise veterinary drugs, medical devices
ReutersApr 24, 2025 2:00 AM
HONG KONG, April 24 (Reuters) - China's customs said on Thursday that they would no longer supervise goods and articles included in the management of drugs, veterinary drugs and medical devices.
Items no longer under supervision as special items entering and leaving the country also include microbial agents for environmental protection, China's General Administration of Customs said.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
What Are On-Chain Perpetual Contracts? Why Are HYPE and ASTER Surging?
The explosive rise of HYPE and ASTER is more than just a price story — it’s a triumph of on-chain derivatives tech, token economics, and community-driven growth. As users demand greater transparency, security, and decentralization, on-chain perpetual contracts are poised to challenge and even replacTradingKey
19 hours ago
Investing in Advanced Chips & Foundry Stocks
All waves of technological development have a foundation, and today’s digital economy is grounded in the semiconductor industry. From smartphones and artificial intelligence to data centers and electric vehiclesTradingKey
20 hours ago
NVIDIA–Oracle–OpenAI: AI Growth Engine or Warning Signs of a Bubble?
TradingKey - Earlier this week, NVIDIA announced a preliminary partnership with OpenAI to jointly deploy 10 gigawatts of compute capacity.TradingKey
Fri, Sep 26
U.S. Q2 GDP Commentary: Unsustainable Growth Rebound, What’s Next for the Stock Market?
TradingKey - On 25 September 2025, the U.S. released the final Q2 GDP data. The data showed that the annualised quarter-on-quarter real GDP growth rate was 3.8%, surpassing the preliminary estimates of 3% in July and 3.3% in August.TradingKey
Fri, Sep 26
Fed Rate Cuts: Will the Russell 2000 Outperform the S&P 500?
TradingKey - On 17 September, the Federal Reserve cut interest rates by 25 basis points, marking the official restart of the rate-cutting cycle. In theory, small-cap stocks, compared to large-cap stocks, benefit more from Fed rate cuts. This is because they are more reliant on external financing...TradingKey
Mon, Sep 22
Tradingkey
